Flagship Biosciences Inc. services

Spatial genomics and transcriptomics using highly multiplexed profiling techniques.

Whole exome sequencing, RNA sequencing, and proprietary NGS panels.

Empowering better decisions through unique, cell-based tissue analysis. Flagship’s pathologist-driven image analysis generates unique cellular data profiles that allow for flexible yet robust quantitative solutions. With one of the largest tissue image analysis operations in the world, we provide contextual biomarker data services powered by proprietary image analysis technology. Our patented, cell-based tissue analysis delivers high-complexity, data-rich tissue interpretations that remove the inherent variability of subjective manual scoring.

Data science customized for your project. Flagship is unique in that we provide actionable intelligence, not just raw data. Our experienced analytics experts work with you to explain how the data impacts your drug development, and to establish the appropriate reporting procedures to give you what you need when you need it. Starting with your biomarker(s) and disease efficacy hypothesis, we create a data profile for each tissue sample. We then curate and process the data into decision-enabling results. Simply put, it’s better data, put to better use.

Expertise in pathology, biology, image analysis, data science, artificial intelligence and assay development. What does your tissue data mean for your development program? What are the next steps in using a tissue data solution for your clinical trial? How do you move forward with a patient selection strategy? Flagship’s team of experts will work with you every step of the way to ensure that you are not only receiving the right data but that you also know what that data means for your biomarker development program and clinical trial.

For rapid and precise cancer care, pathologists and oncologists need dependable diagnostic testing to connect patients to individualized immuno-oncology therapies. Flagship’s TissueInsight® diagnostic service offers you access to robust, contextual data for advanced patient care. Our exclusive, targeted testing in our CAP/CLIA lab provides the most accurate and precise tissue scoring available. Combined with our award-winning technology and sign-off from our experienced pathologists on every project, TissueInsight delivers fast, superior results and data-rich tissue interpretations that remove the inherent variability of subjective manual scoring.

TissueInsight® is a flexible diagnostic service. It can be accessed either directly from a customer LIMS, or through approved digital pathology solution providers. Flagship Biosciences is committed to working with digital pathology solution providers with open standards, solution interoperability and strong customer focus. If you would like to utilize TissueInsight within the framework of an overall digital pathology workflow solution, we recommend the following  trusted partners.